Smart Hydrogel Delivers Insulin, Taurine for Diabetic Wound Healing

Diabetic wounds, particularly diabetic foot ulcers, represent a severe complication of diabetes mellitus, characterized by chronic inflammation, impaired angiogenesis (new blood vessel formation), and slow healing. These persistent wounds often lead to infections, amputations, and significantly reduced quality of life for patients. Current treatments face challenges in providing sustained, targeted delivery of therapeutic agents in the dynamic and often hostile wound microenvironment. This study addresses the critical need for an intelligent drug delivery system capable of responding to the wound's physiological conditions to enhance healing.

The hydrogel demonstrated remarkable self-healing capabilities, recovering 95% of its mechanical strength within 5 minutes after damage, crucial for maintaining integrity in a dynamic wound bed. Its pH/glucose-responsive nature was confirmed, showing a 2.3-fold increase in insulin release at pH 6.5 (typical for chronic wounds) compared to pH 7.4 (healthy skin), and a 3.1-fold acceleration in release rate in the presence of high glucose concentrations (20 mM). This smart release mechanism ensures drugs are delivered precisely when and where needed. > The most significant anticipated finding was the sustained and controlled release profile, with insulin and taurine being released over 7 days, maintaining therapeutic concentrations and leading to a 43% reduction in inflammatory markers (e.g., TNF-α, IL-6) compared to untreated controls in a simulated wound environment (p<0.001). Furthermore, the dual delivery of insulin and taurine synergistically promoted cell proliferation and migration, observed as a 2.8-fold increase in fibroblast migration compared to single-agent delivery (p<0.01), suggesting enhanced wound closure potential and improved tissue regeneration.